Uses of DPP IV inhibitors

Uses of DPP IV inhibitors

BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES

SUPERIOR CONTROL OF BLOOD GLUCOSE IN DIABETES TREATMENT

Methods and formulations for modulating Lyn kinase activity and treating related disorders

Method of Restoring the Incretin Effect

Uses of DPP IV inhibitors

METHODS FOR TREATING DIABETES

Methods and formulations for modulating Lyn kinase activity and treating related disorders

BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES

Glucose-regulating polypeptides and methods of making and using same

Methods and formulations for modulating Lyn kinase activity and treating related disorders

Adult and neonatal stem cell therapy to treat diabetes through the repair of the gastrointestinal tract

Prediction and prophylactic treatment of type 1 diabetes

Method of lowering blood glucose

Potentiation of glucose elimination

Compositions for treating obesity and insulin resistance disorders

Method of restoring the incretin effect

Methods of modulating immunity

Methods for the treatment of IL-1β related diseases

Methods and formulations for treating cardiovascular disease

Uses of DPP IV inhibitors

Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus

Medical and nutritional applications of highly refined cellulose

Methods of delivering stable topical drug compositions

Methods of delivering stable topical drug compositions

Combination of insulin with triazine derivatives and its use for treating diabetes

Compounds for the treatment of metabolic disorders

Method of restoring the incretin effect

Administration of dipeptidyl peptidase inhibitors

N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions and uses thereof

Methods and compositions for delivering peptides

SUGAR-RESPONSIVE GEL AND MEDICINE ADMINISTERING DEVICE

Method of treating ischemic injury with follistatin-like 1 polypeptide

EXENDIN AND EXENDIN AGONISTS FOR EATING DISORDERS

Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia

Drug delivery

Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus

Therapeutic methods for type I diabetes

Method of treatment using fatty acid synthesis inhibitors

Carbohydrate composition for flat glucose response

Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders

COMPOSITIONS USEFUL ESPECIALLY FOR TREATMENT OR PREVENTION OF METABOLIC SYNDROME

PHARMACEUTICAL COMBINATION OF (E)-7-[4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO]PYRIMIDIN-5-YL] (3R,5S)-3,5-DIHYDROXYHEPT-6-ENOIC ACID AND CANDESARTAN

Compositions for treating obesity and insulin resistance disorders

Method Of Treating Diabetes Mellitus

Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases

Medical and nutritional applications of highly refined cellulose

Combination of insulin with triazine derivatives

INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS

Roflumilast for the treatment of diabetes mellitus type 2

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders

USE OF ORGANIC COMPOUNDS

Method of treating inflammation with statins

Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury

Nucleic acids encoding modulators of body weight

Administration of Dipeptidyl Peptidase Inhibitors

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes

Superior Control of Blood Glucose in Diabetes Treatment

Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus

Methods of Modulating Immunity

Topical drug delivery using phosphatidylcholine

Method Of Delivering Stable Topical Drug Compositions

Method of restoring the incretin effect

Methods and compositions for delivering peptides

Amino acid composition for improving glucose tolerance

Potentiators of insulin secretion

Methods for modulating metabolism

Uses of DPP-IV inhibitors

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling

Methods for the treatment of IL-1β related diseases

Drug delivery

Pharmaceutical composition

Method of restoring the incretin effect

Exendin and exendin agonists for eating disorders

Small molecule insulin mimetics absent quinones

Uses of Mammalian Cytokine; Related Reagents

Glucose-regulating polypeptides and methods of making and using same

Methods for the treatment of IL-1β related diseases

Treatment of autoimmune conditions with Copolymer 1 and related copolymers

Novel Use of Liver X Receptor Agonists

TOPICAL DRUG DELIVERY USING PHOSPHATIDYLCHOLINE

Methods for modulating Lyn kinase activity and treating related disorders

COMPOSITIONS COMPRISING ETHER COMPOUNDS AND PHARMACEUTICAL USES THEREFOR

Method of treating ischemic injury with follistatin-like 1 polypeptide

Therapeutic uses of powder

Polyacetylenic compounds for stimulating insulin gene exression, production and secretion

COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

Hypoglycemic activity of osthole

Prediction and prophylactic treatment of type 1 diabetes

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes

Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting MPT

Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes

Insulin resistance improving agent

Methods and compositions of inhibiting complement and cellular activation with Dextran Sulfate

Pharmaceutical compositions for inhibiting intestinal permeability

Methods and compositions for delivering peptides

Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus

NEW PYRAZOLE DERIVATIVES AND DIABETIC MEDICINE CONTAINING THEM

Method of treating insulin resistance with a selective inhibitor of CB2 receptor activity

Synergistic pharmaceutical combination for the prevention or treatment of diabetes

SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE

Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same

Method of treatment using fatty acid synthesis inhibitors

Polymer controlled induced viscosity fiber system and uses thereof

Substituted fused heterocyclic C-glycosides

Modulators of body weight, corresponding nucleic acids and proteins

SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE

Use of creatine analogues and creatine kinase modulators for the prevention and treatment of obesity and its related disorders

Pharmaceutical formulation containing a biguanide and an angiotensin antagonist

Activators of peroxisome proliferator-activated receptors

Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases

Pharmaceutical composition

TRPV1 + SENSORY NEURONS CONTROL OF BETA-CELL STRESS AND ISLET INFLAMMATION IN DIABETES

Carbohydrate composition for flat glucose response

Methods for metabolic modulation

INHIBITORS OF NITRIC OXIDE SYNTHASE

Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy

Exendin agonist analogs to treat diabetes

Novel 4-Dedimethylaminotetracycline derivatives

Diagnosis and treatment of type 2 diabetes and other disorders

Granular preparation containing biguanide compound

USE OF A PHOSPHATE ADSORBENT TO COMBAT VASCULAR DISEASES

Use of liver X receptor agonists

Method of lowering blood glucose and method of treating diabetes and obesity

Materials and methods for modulating metabolism

SUBSTITUTED FUSED HETEROCYCLIC C-GLYCOSIDES

Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators

Methods of treatment using exendin peptides or GLP-1 peptides

Methods for treating diabetes

Treatment for Diabetes

Methods for treating diabetes

Use of LR-90 and LR-102 to overcome insulin resistance

Treatment of type 2 diabetes

FORMULATIONS FOR AMYLIN AGONIST PEPTIDES

Treatment of Diabetes and Related Pathologies

Remedy for diabetes

CHIMERIC PANCREAS

Method of using catalpic acid to treat hyperinsulinemia

Use of a TRPM5 inhibitor to regulate insulin and GLP-1 release

Methods for the treatment of IL-1β related diseases

THERAPEUTIC USES OF AN INSULIN SECRETION ENHANCER

COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus

METHOD OF USE OF PEPTIDE ANTAGONISTS OF ZONULIN TO PREVENT OR DELAY THE ONSET OF DIABETES

Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury and insulin resistance

Methods and compounds for inhibiting amyloid deposits

Steroids derivatives as selective progesterone receptor modulators

Roflumilast for the treatment of diabetes mellitus

Methods for the treatment of diabetes-associated dyslipdemia

Compositions useful especially for treatment or prevention of metabolic syndrome

Polyacetylenic compounds

Methods of treating diabetes mellitus

Therapeutically active triazoles and their use

TRPV1 sensory neurons control of β-cells stress and islet inflammation in diabetes

Use of Exendins and Agonists Thereof for the Treatment of Gestational Diabetes Mellitus

Activators of peroxisome proliferator-activated receptors

Method of restoring the incretin effect

INHALED INSULIN DOSAGE CONTROL DELIVERY ENHANCED BY CONTROLLING TOTAL INHALED VOLUME

Substituted pyrazolo[1,5-a]pyridine compounds and their methods of use

2-ethyl and 2-ethylidene-19-nor-vitamin D compounds

Ejection liquid and ejection method

Compounds for the treatment of metabolic disorders

Prediction and prophylactic treatment of type 1 diabetes

Compounds for the treatment of metabolic disorders

Pharmaceutical composition for treatment of lipid metabolism disorder

Therapeutic uses of powder

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

Method for inhibiting or reversing non-enzymatic glycation

Therapeutic agent for type II diabetes comprising protease-inhibiting compound

USE OF GLP-1 OR ANALOGS IN TREATMENT OF MYOCARDIAL INFARCTION

Uses of DPP-IV inhibitors

Composition and use

USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA

Pyrazole derivatives and diabetic medicine containing them

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

Method for the treatment of metabolic disorders

Use of organic compounds

Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators

Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

Method for the treatment of metabolic disorders

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

Naphthalenedione compounds for treating inflammation related disorders and microbial infection

Rapid Acting Drug Delivery Compositions

Small molecule insulin mimetics absent quinones

Pharmaceutical formulation containing a biguanide and an angiotensin antagonist

Time-release compositions for delivery of [CrO(carboxylate)(HO)]

Amino acid composition for improving glucose tolerance

Ejection liquid, ejection device, ejection cartridge, and method of making droplets from liquid

17-phosphorous steroid derivatives useful as progesterone receptor modulators

Ejection liquid and ejection method

Pharmaceutical composition

USE OF GLP-1 ANALOGS AND DERIVATIVES ADMINISTERED PERIPHERALLY IN REGULATION OF OBESITY

Pharmaceutical compositions and methods for metabolic modulation

Methods for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses

Biocompatible chemically crosslinked hydrogels for glucose sensing

Methods for the treatment of metabolic disorders such as diabetes

Medicinal composition

Pyrazole derivatives and diabetic medicine containing them

Method for inhibiting accelerated atherosclerosis in a subject suffering from hypercholesterolemia or hypertriglyceridemia

Methods for modulating Lyn kinase activity and treating related disorders

2-ethyl and 2-ethylidene-19-nor-vitamin D compounds

Use of tyrosine kinase inhibitor to treat diabetes

Pyrazole derivative, drug composition containing the same and production intermediate therefor

ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS

Sulfonamide derivatives for the treatment of diabetes

Use of compounds

Synergistic composition for the treatment of diabetes mellitus

Glucocorticoid receptor ligands for the treatment of metabolic disorders

Inhibitors of nitric oxide synthase to treat type 1 diabetes

Inhibition of olfactory neurosensory function to treat eating disorders and obesity

Treatment of autoimmune conditions with Copolymer 1 and related Copolymers

Method for preparing peritoneal dialysate

Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases

Potentiation of glucose elimination

Synergistic pharmaceutical combination for the prevention or treatment of diabetes

Diabetogenic rat model

Low dose histone peptide treatment for autoimmune disorders

Inhibition of the β3 subunit of L-type Cachannels

Synergistic composition for the treatment of diabetes mellitus

Use of PDE4 inhibitors for the treatment of diabetes mellitus

Stable topical drug delivery compositions

Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of

Chimeric IL-10

Superior control of blood glucose in diabetes treatment

Vasoactive intestinal polypeptide pharmaceuticals

Composition comprising a gastrin/CCK receptor ligand and an EGF receptor ligand

Anti-Inflammatory Humate Compositions and Methods of Use Thereof

Substituted fused heterocyclic C-glycosides

Therapeutic methods for type I diabetes

GLP-1 derivative and preparation thereof absorbable via mucous membrane

Vanadium compounds as anti-angiogenic agents

Polymer controlled induced viscosity fiber system and uses thereof

Method of using catalpic acid to treat type 2 diabetes and associated disorders

Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use

Synergistic composition for the treatment of diabetes mellitus

Use of exendins and agonists thereof to treat diabetes

Mycobacterium cell wall composition

Pharmaceutical composition comprising N-aryl N′ morpholino/piperidino thiocarbamide derivatives for treating type II diabetes

Supplement foods and pharmaceuticals

Prevention and treatment of cardiovascular pathologies with tamoxifen analogues

Synergistic composition for the treatment of diabetes mellitus

Treatment of diabetes using antibodies to IL-23, IL-23 receptor and IL-17

Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same

Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes

Methods of delivering stable topical drug compositions

Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume

Use of compounds

Methods for treating diabetes

Compositions for treating obesity and insulin resistance disorders

Topical drug delivery using phosphatidylcholine

Vasoactive intestinal polypeptide pharmaceuticals

Treatment of gestational diabetes

Methods and reagents for the treatment of metabolic disorders

Activators of peroxisome proliferator-activated receptors

Pyrazole derivatives and diabetic medicine containing them

Chimeric proteins for diagnosis and treatment of diabetes

Chimeric insulin-gad proteins for treating patients with type 1 diabetes or at risk of developing type 1 diabetes

Chimeric proteins for diagnosis and treatment of diabetes

Treatment of metabolic disorders

Combination therapeutic compositions

Therapeutic use of resveratrol for hyperglycemia

Acylated insulin

Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor

2-ethyl and 2-ethylidene-19-nor-vitamin D compounds

Use of targeted oxidative therapeutic formulation in treatment of type 2 diabetes

Therapeutic agents for diabetes

Method for preparing peritoneal dialysate

Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof

Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof

Compounds for the treatment of metabolic disorders

Methods for facilitating metabolic control

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

Activators of peroxisome proliferator-activated receptor

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

Methods for modulating metabolism

Modified antibody variable domains

Method for the improvement of islet signaling in diabetes mellitus and for its prevention

Pharmaceutical compositions containing exendins

Rapid acting drug delivery compositions

Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy

Method and apparatus treating tissue adjacent a bodily conduit with thermocompression and drugs

Method and composition for preventing or reducing the symptoms of insulin resistance syndrome

Supplement foods and pharmaceuticals

Methods of modulating immunity

Use of enhanced water to improve blood sugar management

4-dedimethylaminotetracycline derivatives

Rat model of diabetic nephropathy

Herbal extract and compound lupinoside and its analogues as anti-diabetic type II drugs from plant Pueraria tuberosa

Methods of treating insulin resistance with an inhibitor of an NAD(P)H oxidase

Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation

Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof

Compositions and methods for treating diabetes

Compositions comprising ether compounds and pharmaceutical uses therefor